220914-32-9Relevant articles and documents
NOVEL COMPOUND FOR PREVENTING OR TREATING NEUROINFLAMMATORY DISEASE AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME
-
Paragraph 0535; 0537, (2021/06/01)
The present invention relates to a novel 2 -halogen or haloalkyl 4,5 -dihydroxy pyrronin analogue and a composition for preventing or treating neuroinflammatory diseases comprising the same as an active ingredient. A composition comprising LPS -stimulated
FLUOROGENIC PROBES FOR MEDIUM CHAIN ACYL-COA DEHYDROGENASE ( MCAD )
-
Page/Page column 51, (2008/06/13)
The present invention relates to compounds useful for detecting the activity of human MCAD, compounds useful for competitively inhibiting human MCAD, as well as methods of manufacture thereof .
Fluoromorphic substrates for fatty acid metabolism: Highly sensitive probes for mammalian medium-chain acyl-CoA dehydrogenase
Froemming, Mary K.,Sames, Dalibor
, p. 637 - 642 (2007/10/03)
(Chemical Equation Presented) Not fussy: A systematic study revealed considerable substrate tolerance of medium-chain acyl-CoA dehydrogenase (MCAD), a member of the β-oxidation pathway for the degradation of fatty acids. Three fluorogenic reporter substra